Seward announces merger and restructuring plans to establish FermionX Ltd
Merger with sister company, C-Tech Electronics Ltd, to form a new vertically integrated manufacturing company.
Seward, makers of Stomacher laboratory blenders and Insterprep sterile media, has merged with its sister company, C-Tech Electronics Ltd, to form a new vertically integrated manufacturing company called FermionX Ltd. There will be no change to Seward’s name; and its high standard of operations known and expected by its customers will also remain the same, but with the added benefit of increased technical resource for R&D, customer support and manufacturing.
The merger represents a significant development for stakeholders, creating a company with combined turnover of circa £6 million. This move consolidates two companies with shared core values on strong customer relationships, quality and value-added products and service.
FermionX will continue to operate through its individual brands; Seward, manufacturers of globally renowned Stomacher lab blenders, and C-Tech Electronics, providing comprehensive electronic contract manufacturing services. The company will leverage both brands’ respective strengths for the benefit of its customers with greater resources for manufacturing, R&D and global sales and distribution footprint.
The merger provides a greater technical resource for Seward to enhance its R&D strategy, an area which has gained emphasis recently with the launch of the Stomacher 400 EVO laboratory blender and Insterprep range of pre-weighed, sterile media.
Under the C-Tech Electronics brand, the company has a highly successful and flexible manufacturing service, providing comprehensive contract electronic manufacturing solutions with expertise and experience from PCB design to complete box-build.
The new company will be led by John Patrick, whose family started C-Tech Electronics. Mr Patrick said: “Establishing FermionX Ltd is an immensely exciting step, developing a company that can provide end-to-end electronic manufacturing solutions, with a final product mind-set. The consolidated resource from all companies will allow us to quickly respond to market opportunities and technology trends to better support our customers.” He added: “While FermionX provides the overriding corporate structure, all company brands will continue to be presented under their existing brand names and to the same high standards of products and service.”
Former Managing Director of Seward, Daniel Crothers, remains with the company as Sales and Marketing Director. Mr Crothers continued: “Seward enjoys a global reputation for quality laboratory products. Under FermionX, the Seward brand will continue to enhance this reputation with emphasis on new product development that adds real value to our laboratory customers. We already have a project list for planned launches in 2017 which our distribution partners are very excited about.”
Technical Director Stuart Ray, who will be heading up the R&D team said: “Both companies have collaborated over the years on product design and development with customers and other strategic partners, FermionX will allow this function to expand and drive the growth of our brands and of the business in general.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance